R. Perdrisot

604 total citations
10 papers, 491 citations indexed

About

R. Perdrisot is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Biomaterials. According to data from OpenAlex, R. Perdrisot has authored 10 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 3 papers in Molecular Biology and 3 papers in Biomaterials. Recurrent topics in R. Perdrisot's work include Neuropeptides and Animal Physiology (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Iron Metabolism and Disorders (3 papers). R. Perdrisot is often cited by papers focused on Neuropeptides and Animal Physiology (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Iron Metabolism and Disorders (3 papers). R. Perdrisot collaborates with scholars based in France. R. Perdrisot's co-authors include J. J. Le Jeune, P Jallet, Daniel Pouliquen, Jean-Paul Swerts, J.C. Schwartz, Bernard Malfroy, Gilles Patey, Sophie De La Baume, G. Gacel and Marie‐Claude Fournié‐Zaluski and has published in prestigious journals such as Biochemical and Biophysical Research Communications, European Journal of Pharmacology and Magnetic Resonance Imaging.

In The Last Decade

R. Perdrisot

10 papers receiving 460 citations

Peers

R. Perdrisot
T. Murray United Kingdom
Newton S. More United States
Wendy Graham United States
Terry Carmack United States
Paul McQuade United States
Naoki Hida United States
T. Murray United Kingdom
R. Perdrisot
Citations per year, relative to R. Perdrisot R. Perdrisot (= 1×) peers T. Murray

Countries citing papers authored by R. Perdrisot

Since Specialization
Citations

This map shows the geographic impact of R. Perdrisot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Perdrisot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Perdrisot more than expected).

Fields of papers citing papers by R. Perdrisot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Perdrisot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Perdrisot. The network helps show where R. Perdrisot may publish in the future.

Co-authorship network of co-authors of R. Perdrisot

This figure shows the co-authorship network connecting the top 25 collaborators of R. Perdrisot. A scholar is included among the top collaborators of R. Perdrisot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Perdrisot. R. Perdrisot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Métayé, Thierry, et al.. (2012). The Presence of Sodium Nitrate in Generator Eluate Decreases the Radiochemical Purity of 99mTc-Sestamibi. Journal of Nuclear Medicine Technology. 40(3). 187–193. 4 indexed citations
2.
Pouliquen, Daniel, et al.. (1993). Liver-directed superparamagnetic iron oxide: Quantitation of T2 relaxation effects. Magnetic Resonance Imaging. 11(2). 219–228. 22 indexed citations
3.
Pouliquen, Daniel, et al.. (1991). Iron oxide nanoparticles for use as an MRI contrast agent: Pharmacokinetics and metabolism. Magnetic Resonance Imaging. 9(3). 275–283. 174 indexed citations
4.
Pouliquen, Daniel, et al.. (1989). Superparamagnetic iron oxide nanoparticles as a liver MRI contrast agent: Contribution of microencapsulation to improved biodistribution. Magnetic Resonance Imaging. 7(6). 619–627. 56 indexed citations
5.
Perdrisot, R., et al.. (1984). 99m Technetium labelled heparin: potential value as a tracer of heparin activity in pharmacokinetic and biodistribution studies.. PubMed. 38(8). 414–6. 2 indexed citations
6.
Schwartz, J.C., et al.. (1980). "Enkephalinase", a newly characterised dipeptidyl carboxypeptidase: properties and possible role in enkephalinergic transmission.. PubMed. 14(2-4). 195–204. 9 indexed citations
7.
Jc, Schwartz, et al.. (1980). Properties variations and possible synaptic functions of "enkephalinase": a newly characterised dipeptidyl carboxypeptidase.. PubMed. 22. 219–35. 15 indexed citations
8.
Llorens‐Cortés, Catherine, G. Gacel, Jean-Paul Swerts, et al.. (1980). Rational design of enkephalinase inhibitors: Substrate specificity of enkephalinase studied from inhibitory potency of various dipeptides. Biochemical and Biophysical Research Communications. 96(4). 1710–1716. 80 indexed citations
9.
Swerts, Jean-Paul, R. Perdrisot, Bernard Malfroy, & J.C. Schwartz. (1979). Is ‘enkephalinase” identical with ‘angiotensin-converting enzyme’?. European Journal of Pharmacology. 53(2). 209–210. 69 indexed citations
10.
Swerts, Jean-Paul, R. Perdrisot, Gilles Patey, Sophie De La Baume, & J.C. Schwartz. (1979). ‘Enkephalinase’ is distinct from brain ‘angiostensin-converting enzyme’. European Journal of Pharmacology. 57(2-3). 279–281. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026